The medtech startup founded by physician and Farapulse inventor Steven Mickelsen is preparing to begin a pivotal study of ...

Field Medical Inc. continues to reap funding from investors for its pulsed field ablation (PFA) system with a $35 million ...

Field Medical announced today that it has closed a Series B funding round worth proceeds totaling $35 million.

"Supported by MAARS, clinicians can deliver personalized care to their patients and protect them appropriately from SCDA ...

Stereotaxis (NYSE:STXS) announced the publication of initial clinical results using its MAGiC robotic magnetic navigation ...

Field Medical has generated another $35 million in venture capital funding for its cardiac pulsed field ablation system to support the launch of a pivotal trial. | The series B financing comes quickly ...

The funding will support the launch of the VERITAS trial while strengthening the company's clinical and regulatory ...

BioStar Capital and Cue Growth co-lead financing to accelerate pivotal trial readiness and expand the ventricular tachycardia ...

The AI analysis resulted in 14 times fewer missed diagnoses of conditions like complete heart block, ventricular tachycardia, ...

For ventricular tachycardia (VT), catheter ablation is often seen as an option of last resort, however, some are questioning whether there has been too much emphasis on antiarrhythmic medication.

Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.